Strata Critical Medical Inc.
SRTA | NASDAQ
$5.40
+$0.06 (+1.12%)
At close: Sep 21, 2026, 4:00 PM ET
$5.31
-$0.09 (-1.67%)
Pre-market:
Sep 22, 2026, 4:56 AM ET
Market Data
Market Cap $462.05M
Enterprise Value $448.75M
Beta 2.26
Average Volume 1.1M
Shares Outstanding (Diluted) 86.21M
Shares Change YoY 6.05%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US0926671043
Price Performance
Price Change 1M -13.5%
Price Change 3M -3.0%
Price Change 6M 23.3%
Price Change YTD 9.5%
Price Change 1Y -8.0%
Price Change 3Y 102.3%
Price Change 5Y -53.6%
1M CAGR (ann.) -4.5%
1Y CAGR (ann.) 2.7%
5Y CAGR (ann.) -11.5%
All-Time CAGR -8.4%
Valuation
PE Ratio -22.50
Forward PE 44.00
PEG Ratio 0.03
Forward PEG -0.10
PS Ratio 1.83
Forward PS 1.40
PB Ratio 1.67
P/FCF Ratio -10.31
P/Adj. FCF Ratio -7.71
P/OCF Ratio -15.00
EV/Sales 1.75
EV/EBIT -17.50
EV/EBITDA -47.96
EV/FCF -9.91
Earnings Yield -4.4%
FCF Yield -9.7%
Adj. FCF Yield -13.0%
Financial Health
Net Cash $22.75M
Total Debt $4.26M
Cash & Short-Term Investments $22.75M
Total Assets $332.7M
Current Ratio 2.64
Quick Ratio 2.64
Debt / Equity Ratio 0.02
Debt / EBITDA -0.45
Debt / FCF -0.09
OCF / Debt -6.35
Interest Coverage 0.00
Altman Z-Score 5.33
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 20.6%
Operating Profit Margin -8.0%
EBITDA Margin -3.7%
Net Profit Margin 15.7%
FCF Margin -17.7%
Adj. FCF Margin -23.7%
SBC / Revenue 4.0%
SBC Impact (per share) -33.8%
Returns
Return on Assets 12.1%
Return on Equity 14.3%
Return on Invested Capital -7.1%
Return on Capital Employed -7.1%
Return on Tangible Assets 24.3%
Historical Growth (CAGR)
Revenue CAGR 3Y 10.4%
Revenue CAGR 5Y 46.0%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 54.9%
EPS CAGR 5Y 6.5%
EPS CAGR 10Y N/A
FCF CAGR 3Y -17.1%
FCF CAGR 5Y 0.4%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 6
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date N/A
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $7.25
Price Target Upside 34.3%
Cash Flow
Operating Cash Flow $-27.02M
Free Cash Flow $-45.3M
Adj. Free Cash Flow $-60.63M
FCF Per Share -$0.51
OCF Per Share -$0.36
OCF/S Ratio -12.1%
Income Statement
Revenue $255.98M
Gross Profit $52.62M
Operating Income $-20.41M
EBITDA $-9.36M
Net Income $40.22M
EPS (Diluted) -$0.24
Revenue / Employee $782.8K
Profit / Employee $123K
Employees 327
Add to Watchlist
Select watchlists to add or remove SRTA